|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 760.00 INR | -1.39% |
|
-6.48% | +110.69% |
| 21/10 | Solara Active Pharma Sciences Limited, Q2 2025 Earnings Call, Oct 21, 2024 | |
| 31/07 | Solara Active Pharma Sciences' Puducherry, India Facility Clears EU GMP Inspection | MT |
| Capitalization | 3.7TCr 44Cr 42Cr 38Cr 34Cr 62Cr 68Cr 479.32Cr 176.94Cr 1.52TCr 163.84Cr 160.3Cr 6.64TCr | P/E ratio 2025 * |
43.3x | P/E ratio 2026 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise value | 3.7TCr 44Cr 42Cr 38Cr 34Cr 62Cr 68Cr 479.32Cr 176.94Cr 1.52TCr 163.84Cr 160.3Cr 6.64TCr | EV / Sales 2025 * |
2.41x | EV / Sales 2026 * | 2.2x |
| Free-Float |
-
| Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Solara Active Pharma Sciences Limited
More press releases
| 1 day | -1.27% | ||
| 1 week | -6.48% | ||
| Current month | -10.53% | ||
| 1 month | -2.03% | ||
| 3 months | +0.78% | ||
| 6 months | +74.42% | ||
| Current year | +110.69% |
1 week
755.00
813.00
1 month
731.00882.80
Current year
350.00882.80
1 year
317.55882.80
3 years
286.001 215.00
5 years
286.001 859.95
10 years
134.501 859.95
| Director | Title | Age | Since |
|---|---|---|---|
Poorvank Purohit
CEO | Chief Executive Officer | - | 03/02/2023 |
| Director of Finance/CFO | - | 08/03/2024 | |
| Chief Operating Officer | 52 | 01/01/2024 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 11/04/2018 | |
| Director/Board Member | 56 | 11/04/2018 | |
Arun Pillai
BRD | Director/Board Member | 63 | 04/08/2021 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 92 M€ | +15.66% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.39% | -6.48% | +128.02% | -34.45% | 44Cr | ||
| -0.50% | -1.69% | +33.70% | +227.51% | 72TCr | ||
| +0.22% | +0.53% | +17.17% | +105.77% | 49TCr | ||
| -0.25% | -2.05% | -3.36% | -9.83% | 36TCr | ||
| -0.51% | -3.21% | +17.68% | +40.01% | 31TCr | ||
| -2.69% | -0.83% | -2.65% | +39.08% | 26TCr | ||
| +0.45% | +0.55% | +0.31% | -32.03% | 23TCr | ||
| -0.27% | 0.00% | +3.80% | +27.06% | 21TCr | ||
| -0.53% | -2.01% | +3.17% | +18.45% | 20TCr | ||
| -0.68% | -0.92% | +2.46% | +30.76% | 15TCr | ||
| Average | -0.36% | -2.23% | +20.03% | +41.23% | 29.22TCr | |
| Weighted average by Cap. | -0.19% | -1.61% | +13.06% | +82.40% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.54TCr 18Cr 17Cr 16Cr 14Cr 26Cr 28Cr 198.85Cr 73Cr 630.87Cr 68Cr 67Cr 2.75TCr | 1.68TCr 20Cr 19Cr 17Cr 16Cr 28Cr 31Cr 217.5Cr 80Cr 690.04Cr 74Cr 73Cr 3.01TCr |
| Net income | 86Cr 1.01Cr 95.9L 88.87L 79.04L 1.43Cr 1.58Cr 11Cr 4.08Cr 35Cr 3.78Cr 3.7Cr 153.21Cr | 155.9Cr 1.84Cr 1.75Cr 1.62Cr 1.44Cr 2.6Cr 2.88Cr 20Cr 7.45Cr 64Cr 6.9Cr 6.75Cr 279.36Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
2,156
Sector
Pharmaceuticals
Calendar
30/01/2025
- Q3 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/24/11 | 760.00 ₹ | -1.39% | 70,338 |
| 10/24/10 | 770.70 ₹ | -1.17% | 88,304 |
| 09/24/09 | 779.85 ₹ | -0.90% | 108,901 |
| 06/24/06 | 786.95 ₹ | -1.86% | 111,177 |
| 05/24/05 | 801.90 ₹ | -1.44% | 137,263 |
Delayed Quote NSE India S.E., December 11, 2024 at 03:12 pm IST
More quotes
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
770.70INR
Average target price
566.00INR
Spread / Average Target
-26.56%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOLARA Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition